跳到正文

AN2 Therapeutics, Inc.(ANTX)内部人交易:高管与董事近期交易

过去 18 个月,共有 14 位内部人为 AN2 Therapeutics, Inc.(ANTX)报告了 51 笔 Form 4 交易(最近一笔 2026-11-06)。

日期内部人职务类型股数市值
2026-11-06Eizen Joshua MChief Operating Officer and Chief Legal Officer卖出2,826$11,926
2026-10-13Aziz Kabeer董事买入2,465$0
2026-10-13Martin Patricia A.董事买入389$0
2026-10-13Marks Gilbert Lynn董事买入2,283$0
2026-09-16Trenor Cameron C. IIIChief Medical Officer买入116,667$0
2026-09-11Readnour Robin Shane董事卖出523$3,148
2026-09-11Readnour Robin Shane董事卖出585$3,522
2026-09-08Readnour Robin Shane董事卖出2,877$17,463
2026-09-08Readnour Robin Shane董事卖出3,223$19,564
2026-09-08Readnour Robin Shane董事卖出4,725$28,444
2026-09-08Readnour Robin Shane董事卖出5,294$31,870
2026-09-04Williams Sarah JoannePrincipal Accounting Officer卖出272$1,504
2026-09-02FitzPatrick Margaret M董事买入2,098$11,602
2026-08-19Readnour Robin Shane董事卖出16,696$100,343
2026-08-19Readnour Robin Shane董事卖出18,706$112,423
2026-08-14Zakrzewski Joseph S董事卖出405,880$0
2026-07-10Eizen Joshua MChief Operating Officer and Chief Legal Officer卖出5,945$24,791
2026-07-10Martin Patricia A.董事买入766$0
2026-07-10Marks Gilbert Lynn董事买入2,789$0
2026-07-10Aziz Kabeer董事买入2,852$0
2026-06-02Williams Sarah JoannePrincipal Accounting Officer卖出265$1,174
2026-04-10Aziz Kabeer董事买入3,775$0
2026-04-10Martin Patricia A.董事买入1,192$0
2026-04-10Marks Gilbert Lynn董事买入3,775$0
2026-03-05Williams Sarah JoannePrincipal Accounting Officer卖出327$347

来源:SEC Form 4 申报文件 · 截至 2026-11-06